Zonisamide add-on for drug-resistant partial epilepsy

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 12, 2013, Pages

  Carmichael, Katie ^a   Pulman, Jennifer ^a   Lakhan, Shaheen Emmanuel ^b   Parikh, Prachi ^c   Marson, Anthony G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Global Neuroscience Initiative Foundation   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ZONISAMIDE; ANTICONVULSIVE AGENT; ISOXAZOLE DERIVATIVE;

ADD ON THERAPY; AGITATION; ANOREXIA; ATAXIA; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOCAL EPILEPSY; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DRUG COMBINATION; DRUG RESISTANCE; META ANALYSIS; METHODOLOGY; TREATMENT FAILURE;

ANTICONVULSANTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; HUMANS; ISOXAZOLES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT FAILURE;

EID: 84897368218     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001416.pub3     Document Type: Review

References (27)

1. Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitensky V. Zonisamide is a effective adjunctive therapy for patients with refractory partial epilepsy: results from a randomised, double-blind, placebo-controlled study. Epilepsia 2004;45(Suppl 3):155.
2. Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005;46(1):31-41.
3. Brodie MJ, Vespignani H. Efficacy of zonisamide against refractory partial seizures in an evaluable patient population. Epilepsia 2005;46(Suppl 6):117-8.
4. Brodie MJ, Vespignani H, Solyom A, Bitensky V. Dose-dependent safety and efficacy of zonisamide in refractory, localization-related epilepsy: a randomized, double-blind, placebo-controlled trial. Epilepsia 2004;45(Suppl 7):131.
5. Faught E, Ayala R, Montouris G, Leppik IE. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57(10):1774-9.
6. Lu Y, Xiao Z, Yu W, Xiao F, Xiao Z, Hu Y, et al.Efficacy and safety of adjunctive zonisamide in adult patients with refractory partial-onset epilepsy. Clinical Drug Investigation 2011;31(4):221-9.
7. Sackellares JC, Ramsay RE, Wilder BJ, Browne III TR, Shellenberger MK. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 2004;45(6):610-7.
8. Wilder BJ, Ramsay RE, Guterman A. A double blind multicenter placebo controlled study of the efficacy of zonisamide in the treatment of complex partial seizures in medically refractory patients. Internal report of the Dainippon Pharmaceutical Company 1986.
9. Schmidt D, Jacob R, Loiseau P, Deisenhammer E, Klinger D, Despland A, et al.Zonisamide for add-on treatment of refractory partial epilepsy: a European double blind trial. Epilepsy Research 1993;15(1):67-73.
10. Shimizu A, Yamamoto J, Yamada Y, Tanaka M, Kawasaki T. The antiepileptic effect of zonisamide on patients with refractory seizures and its side effects. Japanese Journal of Psychiatry and Neurology 1988;42(3):583.
11. Anderson TJ, Donaldson IM, McConnell H, Pollock M, Dobbs BR. Zonisamide: comparison with sodium valproate as additional treatment in refractory seizures. New Zealand Medical Journal 1988;101(854):611.
12. Baulac M, Leppik IE. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Epilepsy Research 2007;75:75-83.
13. British National Formulary. www.bnf.org (accessed May 2013).
14. Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995;346:140-4.
15. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935 - 1984. Epilepsia 1993;34:453-68.
16. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
17. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org.
18. Leppik IE. Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 2004;S13:S5-S9.
19. Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW. Carbamazepine versus valproate monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: ]
20. Marson A, Al-Kharusi A, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al.The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. The Lancet 2007;369(9566):1000-15.
21. McCullagh P, Nelder JA. Generalized Linear Models. Second Edition. London: Chapman and Hall, 1989.
22. Mori A, Noda Y, Packer L. The anticonvulsant zonisamide scavenges free radicals. Epilepsy Research 1998;30:153-8.
23. Sander JW, Shorvon SD. Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery, and Psychiatry 1996;61(5):433-43.
24. Ueda Y, Doi T, Tokumaru J, Willmore LJ. Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures. Molecular Brain Research 2003;116(1-2):1-6.
25. Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: ]
26. Marson AG, Kadir ZA, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996;313:1169-74.
27. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38(8):859-80.